Breaking News Instant updates and real-time market news.

BBRY

BlackBerry

$9.23

0.09 (0.98%)

, MKC

McCormick

09:21
09/28/17
09/28
09:21
09/28/17
09:21

On The Fly: Pre-market Movers

UP AFTER EARNINGS: BlackBerry (BBRY), up 5.9%... McCormick (MKC), up 2.7%... Conagra Brands (CAG), up 2%... Thor Industries (THO), up 4.2%. ALSO HIGHER: Hain Celestial (HAIN), up 6.4% after entering into a cooperation agreement with Engaged Capital... AbbVie (ABBV), up 2.1% after announcing the resolution of Humira patent disputes with Amgen (AMGN). DOWN AFTER EARNINGS: Rite Aid (RAD), down 8.8%... Vail Resorts (MTN), down 4%... Accenture (ACN), down 2.6%... Ferrellgas Partners LP (FGP), down 3.1%. ALSO LOWER: Sherwin-Williams (SHW), down marginally after reducing its guidance.

BBRY

BlackBerry

$9.23

0.09 (0.98%)

MKC

McCormick

CAG

Conagra Brands

THO

Thor Industries

HAIN

Hain Celestial

$40.43

-0.16 (-0.39%)

ABBV

AbbVie

RAD

Rite Aid

MTN

Vail Resorts

ACN

Accenture

FGP

Ferrellgas Partners LP

SHW

Sherwin-Williams

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

  • 08

    Nov

  • 08

    Nov

BBRY BlackBerry
$9.23

0.09 (0.98%)

09/22/17
RBCM
09/22/17
NO CHANGE
Target $9.5
RBCM
Sector Perform
BlackBerry can use $1.6B of cash on acquisitions, says RBC Capital
RBC Capital analyst Paul Treiber says BlackBerry (BBRY) has $2.36B in cash after the $940M award from Qualcomm (QCOM). The company can use up to $1.6B of the cash on acquisitions, which may be accretive to earnings and the stock price, Treiber tells investors in a research note. He fells an acquisition of a company with organic growth above BlackBerry's targeted 10%-15% software growth "would be a tailwind to BlackBerry's organic growth." Treiber expects in-line Q2 results from BlackBerry on September 28 and keeps a Sector Perform rating on the shares.
08/07/17
08/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. XPO Logistics (XPO) resumed with an Outperform at William Blair. 2. BlackBerry (BBRY) reinstated with a Sell at Goldman Sachs. 3. Brighthouse Financial (BHF) was initiated with a Sell at Citi, a Market Perform at Keefe Bruyette, FBR Capital, and Wells Fargo, a Sector Perform at RBC Capital, and a Neutral at Credit Suisse. 4. Zoetis (ZTS) reinstated with a Neutral at Goldman Sachs. 5. BeiGene (BGNE) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/17
ADAM
08/11/17
NO CHANGE
Target $10
ADAM
Hold
BlackBerry equipped to invest for growth, says Canaccord
Canaccord analyst T. Michael Walkley said Blackberry management gave an upbeat presentation at the firm's conference and explained how the company has completed its transformation into an enterprise software and services company. The analyst noted the company's strong balance sheet, including its cash balance, lead him to believe they have the capital to invest for growth by both hiring and through acquisition. Walkley maintained his Hold rating and $10 price target on Blackberry shares.
09/22/17
BOFA
09/22/17
NO CHANGE
Target $8
BOFA
Underperform
BlackBerry valuation unattractive, says BofA/Merrill
BofA/Merrill analyst Daniel Bartus continues to view BlackBerry's valuation as unattractive saying the company has a long path to profitability, the Enterprise segment valuation is too high, QNX is low growth and at risk of share loss near-term, and Q1 software/services growth was due to a shift from handset related revenues. The analyst raised his price target on BlackBerry to $8 from 7.50 and maintained an Underperform rating on shares.
MKC McCormick

06/30/17
FBCO
06/30/17
NO CHANGE
Target $108
FBCO
Outperform
McCormick sets up for 'beat-and-raise' Q3 report, says Credit Suisse
Credit Suisse analyst Robert Moskow said he was surprised by the negative reaction in McCormick shares following the company's Q2 report and reiteration of its FY17 earnings outlook. He thinks strong volume growth, international price increases and easier gross margin comparisons will drive Q3 results and give management sufficient visibility to raise its earnings guidance at that time. The analyst, who notes that his $4.53 EPS estimate for 2018 is well above consensus, keeps an Outperform rating on McCormick shares.
07/28/17
JEFF
07/28/17
UPGRADE
Target $110
JEFF
Buy
McCormick upgraded to Buy from Hold at Jefferies
Jefferies analyst Akshay Jagdale upgraded McCormick to Buy and raised his price target for the shares to $110 from $95. The analyst believes the recent underperformance provides a good entry point and thinks the RB Foods acquisition will accelerate earnings growth .
06/16/17
GSCO
06/16/17
INITIATION
Target $101
GSCO
Neutral
McCormick initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Adam Samuelson started McCormick with a Neutral rating and $101 price target. The analyst views the valuation as full and believes e-commerce disruption risk is high.
06/16/17
06/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hasbro (HAS) initiated with a Buy at Argus. 2. Kindred Biosciences (KIN) initiated with a Buy at Aegis. 3. Stanley Black & Decker (SWK) was initiated with a Buy at Seaport Global and resumed with an Outperform at Raymond James. 4. McCormick (MKC) initiated with a Neutral at Goldman Sachs. 5. Texas Instruments (TXN) resumed with a Market Perform at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CAG Conagra Brands

08/28/17
UBSW
08/28/17
NO CHANGE
Target $65
UBSW
Buy
UBS believes Pinnacle Food/Conagra deal could yield sizable synergies
UBS analyst Steven Strycula explored five scenarios for Pinnacle Foods (PF) to create shareholder value, one of which is a combination with Conagra (CAG). The analyst believes a tie-up could deliver earnings accretion and sizable synergies within the frozen and condiment/dressing categories. He also said Pinnacle could make bolt-on acquisitions that could represent a transformational asset for larger, growth challenged sponsors. Strycula reiterated his Buy rating and $65 price target on Pinnacle Foods shares.
07/26/17
JEFF
07/26/17
NO CHANGE
Target $50
JEFF
Buy
Hain Celestial management would sell at right price, says Jefferies
After hosting investor meetings with management, Jefferies analyst Akshay Jagdale performed additional work to quantify Hain Celestial's (HAIN) strategic value. The analyst believes there would be "significant strategic interest" in Hain and that management "is a willing seller" at the right price. A deal for Hain makes the most sense for Pinnacle Foods (PF), Jagdale tells investors in a research note. He analyzed five scenarios in which hypothetical strategic buyers acquire Hain for $70 per share. The organic and natural products company closed yesterday up 1c to $43.80. Jagdale estimates that by year three, the deal would be 8% accretive to Pinnacle's earnings, 4% to General Mills' (GIS) and Conagra Brands' (CAG), 1.4% to Campbell Soup's and dilutive to Kellogg's (K). The analyst sees limited downside to shares of Hain and keeps a Buy rating on the stock with a $50 price target.
07/06/17
JEFF
07/06/17
NO CHANGE
Target $46
JEFF
Buy
Conagra Brands weakness a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale views the recent weakness in shares of Conagra Brands as a buying opportunity. The company's guidance is likely conservative and its portfolio reshaping, which the market is missing, has the potential to unlock "significant" value, Jagdale tells investors in a research note. He reiterates a Buy rating on Conagra with a $46 price target.
06/30/17
UBSW
06/30/17
NO CHANGE
Target $33
UBSW
Sell
Conagra Brands valuation remains elevated given fundamentals, says UBS
UBS analyst Steven Strycula believes the valuation for Conagra Brands remains elevated given its current fundamentals. The analyst cut his estimates to reflect lower sales and more muted upside for margins. Strycula said the breadth of the company's portfolio makes it challenging to move the needle, but he expects its robust innovation pipeline to boost sales beginning next year. Strycula reiterated his Sell rating and lowered his price target to $33 from $35 on Conagra Brands shares.
THO Thor Industries

09/21/17
RHCO
09/21/17
NO CHANGE
RHCO
RV demand remains strong, says SunTrust
After attending RV Open House and conducting checks, SunTrust analyst Michael Swartz says that demand for RVs remained "strong" into September. He says that in past years, there has been a lull in RV demand ahead of RV Open House, but he says that this does not appear to have occurred this year. He adds that he believes the sector should get "some boost" from the recent hurricanes. The analyst reports that Thor Industries (THO) is gaining share, and he keeps a Buy rating on the stock. He believes that Winnebago (WGO) is seeing " strong demand for Winnebago/Grand Design towable," but he keeps a Hold rating on that stock.
09/28/17
RHCO
09/28/17
NO CHANGE
RHCO
Thor Industries price target raised to $140 from $125 at SunTrust
SunTrust analyst Michael A. Swartz raised his price target on Thor citing the company's higher than expected Q4 EPS and the higher than expected Q4 gross margin of its Jayco unit. Calling the company's overall Q4 results "strong," and saying that its backlog indicates that its revenue will increase at least 10% in fiscal 2018, the analyst keeps a Buy rating on the shares.
09/11/17
09/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: DowDuPont (DWDP) initiated with a Buy at BofA/Merrill and an Underweight at Barclays. 2. Brookfield Infrastructure (BIP) initiated with an Outperform at BMO Capital. 3. Micron (MU) initiated with an Outperform at FBN Securities. 4. TechnipFMC (FTI) initiated with a Hold at HSBC. 5. Thor Industries (THO) initiated with a Hold at Aegis. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
AGIS
09/11/17
INITIATION
Target $113
AGIS
Hold
Thor Industries initiated with a Hold at Aegis
Aegis analyst Rommel Dionisio initiated Thor Industries with a Hold and a $113 price target. The analyst said shares appear fairly valued and notes margin opportunities are limited given rising labor rates and negative product mix shift trends.
HAIN Hain Celestial
$40.43

-0.16 (-0.39%)

08/29/17
JPMS
08/29/17
NO CHANGE
JPMS
Neutral
JPMorgan 'somewhat skeptical' on Hain Celestial guidance
JPMorgan analyst Ken Goldman views Hain Celestial's (HAIN) Q4 results today as "slightly positive." The quarter overall was "fine," with sales growth coming in slightly above expectations and the gross margin in line, Goldman tells investors in a post-earnings research note. The analyst remains "somewhat skeptical" that Hain's FY18 outlook is achievable given "challenged" data in Nielsen as well as Amazon's (AMZN) Whole Foods' renewed emphasis on its 365 store brand. Goldman has a Neutral rating on Hain, which is rallying 6% following today's results to $43.00.
08/01/17
08/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hain Celestial (HAIN) initiated with a Hold at Loop Capital. 2. Centennial Resource Development (CDEV) initiated with an Overweight at JPMorgan. 3. Neos Therapeutics (NEOS) initiated with an Overweight at Cantor. 4. Celldex (CLDX) assumed with a Buy at H.C. Wainwright. 5. SilverBow Resorces (SBOW) initiated with a Neutral at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/22/17
SUSQ
08/22/17
DOWNGRADE
SUSQ
Neutral
Hain Celestial downgraded to Neutral from Positive at Susquehanna
09/08/17
BMOC
09/08/17
NO CHANGE
BMOC
Hain Celestial could benefit from Whole Foods deal, says BMO Capital
BMO Capital says that Hain Celestial (HAIN) could benefit from Amazon's (AMZN) acquisition of Whole Foods. The firm reasons that the deal will result in "increased distribution of natural/organic foods." The firm adds that " Hain is also somewhat insulated as it's difficult to source private-label natural/organic products at scale."
ABBV AbbVie

09/27/17
FBCO
09/27/17
NO CHANGE
Target $17
FBCO
Outperform
Coherus Biosciences price target lowered to $17 from $24 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Coherus Biosciences (CHRS) to $17 from $24 as she is pushing her worldwide launch timeline assumption to 2022 from 2020 for the biosimilar Humira from AbbVie (ABBV). The analyst reiterates an Outperform rating on Coherus Biosciences shares.
09/25/17
09/25/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UAA) downgraded to Neutral from Buy at Guggenheim. 2. VF Corp. (VFC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Edward Yruma saying the company's "consistent" results are adequately reflected in the current valuation. 3. Quest Diagnostics (DGX) downgraded to Market Perform from Outperform at Raymond James with analyst Nicholas Jansen citing the preliminary 2018 Clinical Laboratory Fee Schedule, or CLFS, rates released Friday evening, which creates an overhang. 4. AbbVie (ABBV) downgraded to Neutral from Buy at UBS with analyst Marc Goodman saying that shares are up 40% year-to-date. 5. Albemarle (ALB) downgraded to Neutral from Outperform at Baird with analyst Ben Kallo saying he thinks near-term execution is largely priced into the stock and he believes the shares are fully valued at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/25/17
UBSW
09/25/17
DOWNGRADE
Target $92
UBSW
Neutral
AbbVie downgraded to Neutral from Buy at UBS
UBS analyst Marc Goodman downgraded AbbVie to Neutral with the shares up 40% year-to-date. Investors this year have gained more confidence in the duration of Humira and in the company's pipeline, Goodman tells investors in a research note. After pushing out his assumption for U.S. biosimilar competition for Humira to 2022 from 2021, the analyst raised his price target for AbbVie shares to $92 from $79. Goodman, however, no longer sees enough upside to warrant a Buy rating. AbbVie closed Friday up 7c to $87.48.
09/25/17
JEFF
09/25/17
NO CHANGE
Target $200
JEFF
Buy
Jefferies explains how Amgen can re-rate higher like AbbVie
Jefferies analyst Michael Yee believes the 2018-2020 consensus estimates for Amgen (AMGN) may be too low if Mylan's (MYL) biosimilar of Neulasta doesn't get approved next month. The Biosimilar User Fee Act date is October 9. Investors may become more confident in the durability of Amgen's franchise given that AbbVie (ABBV) defended Humira and re-rated to a higher valuation, Yee tells investors in a research note. The key issue keeping Amgen's price-to-earnings multiple below peers at 12 to 13 times over the past couple of years is investor fear of biosimilars primarily against Neulasta and Enbrel, Yee argues. He sees a failed approval for Mylan as setting the tone for a higher multiple like AbbVie. The analyst has a Buy rating on Amgen shares with a $200 price target.
RAD Rite Aid

09/19/17
RBCM
09/19/17
INITIATION
RBCM
Sector Perform
Rite Aid initiated with a Sector Perform at RBC Capital
RBC Capital analyst George Hill started coverage of Rite Aid with a $2.50 price target and a Sector Perform rating.
09/12/17
09/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Outperform at Macquarie. 2. Bunge (BG) initiated with a Neutral at Baird. 3. Rite Aid (RAD) initiated with a Hold at Loop Capital. 4. Nike (NKE) was initiated with an Outperform at Bernstein, while Under Armour (UA) was initiated with an Underperform. 5. Houlihan Lokey (HLI) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
LOOP
09/11/17
INITIATION
Target $2.5
LOOP
Hold
Rite Aid initiated with a Hold at Loop Capital
Loop Capital analyst Andrew Wolf started Rite Aid (RAD) with a Hold rating and $2.50 price target, stating that he views the company's re-worked store sale to Walgreens (WBA) as a "re-launch of Rite Aid's turnaround efforts" and believes it lacks intermediate term earnings visibility.
08/23/17
UBSW
08/23/17
NO CHANGE
Target $96
UBSW
Buy
Walgreens Boots Alliance should see upside from new Rite Aid deal, says UBS
UBS analyst Michael Cherny said his review of the new Walgreens Boots Alliance (WBA) deal with Rite Aid (RAD) would provide immediate accretion from synergy opportunities if the deal is approved. He believes it can provide meaningful upside to earnings as well as remove the lack of clarity on capital deployment-driven earnings contribution. Thus, he sees the shares as having a positive risk/reward skew. Cherny reiterated his Buy rating and lowered his price target to $96 from $97 on Walgreens shares.
MTN Vail Resorts

08/30/17
KEYB
08/30/17
INITIATION
Target $250
KEYB
Overweight
Vail Resorts resumed with an Overweight at KeyBanc
KeyBanc analyst Brett Andress resumed coverage of Vail Resorts with an Overweight rating and $250 price target.
07/21/17
WBLR
07/21/17
INITIATION
WBLR
Outperform
Vail Resorts initiated with an Outperform at William Blair
William Blair analyst Ryan Sundby started Vail Resorts with an Outperform rating.
07/19/17
MACQ
07/19/17
DOWNGRADE
Target $5
MACQ
Neutral
Peak Resorts downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Matthew Brooks downgraded Peak Resorts (SKIS) to Neutral and lowered its price target to $5 due to increased competition from Vail Resorts (MTN) and Aspen/KSL in the Northeast, which could be a headwind to pass sales and valuation. Further, the analyst sees a difficult weather comp in the Northeast that could outweigh the tailwind from an easy comp in the Midwest.
06/09/17
BOFA
06/09/17
NO CHANGE
Target $228
BOFA
Buy
Vail Resorts price target raised to $228 from $205 at BofA/Merrill
BofA/Merrill analyst Shaun Kelley raised Vail Resorts' price target to $228 from $205 citing the solid Q3 report. The analyst views Vail as a best in-class company given core earnings upside potential, strong season pass sales, solid free cash flow, and Whistler and Stowe synergy beneifts. Kelly rates Vail Resorts a Buy.
ACN Accenture

09/22/17
BARD
09/22/17
NO CHANGE
Target $148
BARD
Neutral
Accenture risk/reward into earnings 'decent,' says Baird
Baird analyst David Koning views Accenture risk/reward as "decent" into Q4 earnings as consensus estimates are biased higher, but notes shares have been strong since September. The analyst said foreign exchange and acquisitions have become increasingly positive for 2018 and believes revenue growth will be guided to 7%-9%, versus consensus of 7%. Koning believes valuation will hold or improve a bit as reported growth is likely to accelerate to the high single digits in FY18. The analyst raised his price target to $148 from $142 and maintains a Neutral rating.
08/04/17
FBCO
08/04/17
NO CHANGE
Target $80
FBCO
Outperform
Cognizant price target raised to $80 from $70 at Credit Suisse
After its Q2 report, Credit Suisse analyst Charles Brennan said Cognizant (CTSH) remains one of the fastest growing companies in Computer Services & IT Consulting and deserves a valuation more in line with slower-growing peer Accenture (ACN). The analyst raised his price target on Cognizant to $80 from $70 and keeps an Outperform rating on the shares.
09/12/17
BOFA
09/12/17
INITIATION
Target $150
BOFA
Buy
Accenture reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Jason Kupferberg reinstated Accenture with a Buy and a $150 price target due to visible 9-10% earnings growth over the next few years, and the commitment to margin improvement and buybacks.
09/26/17
KEYB
09/26/17
NO CHANGE
KEYB
Accenture, IBM to benefit from shift to AI, says KeyBanc
KeyBanc analyst Arvind Ramnani says that while the promise of Artificial Intelligence is exciting, the path is complex, which he believes provides a "unique opportunity" for IT Services firms that can accelerate its adoption. The analyst thinks Accenture (ACN), IBM (IBM), DXC Technology (DXC), and EPAM Systems (EPAM), among others, could benefit from the shift to AI.
FGP Ferrellgas Partners LP

12/05/16
PIPR
12/05/16
UPGRADE
Target $6.5
PIPR
Neutral
Ferrellgas Partners LP upgraded to Neutral on valuation at Piper Jaffray
Piper Jaffray analyst Brian Gamble upgraded Ferrellgas Partners LP to Neutral from Underweight saying the shares are now fairly valued following the 80% distribution cut. He lowered his price target for the stock to $6.50 from $7. Citi this morning upgraded Ferrellgas to Buy.
12/08/16
RBCM
12/08/16
UPGRADE
RBCM
Sector Perform
Ferrellgas Partners LP upgraded at RBC Capital
As noted earlier, RBC Capital upgraded Ferrellgas to Sector Perform from Underperform. Analyst TJ Schultz says that the company's 80% distribution cut should enable it to reduce its debt, However, the analyst still expects the company to "temporarily" violate its debt covenants next summer, and he says the covenants could "become a bigger issue" subsequently. Target to $6 from $11.
03/09/17
BOFA
03/09/17
NO CHANGE
Target $5
BOFA
Underperform
Ferrellgas Partners price target lowered to $5 from $6 at BofA/Merrill
BofA/Merrill analyst Gabe Moreen lowered Ferrellgas Partners LP's price target to $5 and reiterated his Underperform rating to reflect persistent leverage concerns and the pending lawsuit with Eddystone. The company disclosed it has been named with Bridger in a lawsuit by Eddystone Rail Company in February 2017 relating to an arbitration claim against Jamex Transfer Services, a former subsidiary of Bridger for payment deficiency for the use of Eddystone's rail offloading facility in Tralner, PA. The analyst said it is unclear what Ferrellgas' payment responsibility is at this point.
12/08/16
RBCM
12/08/16
UPGRADE
RBCM
Sector Perform
Ferrellgas Partners upgraded to Sector Perform from Underperform at RBC Capital
SHW Sherwin-Williams

07/11/17
SBSH
07/11/17
NO CHANGE
SBSH
Citi views paint survey as positive for Sherwin-Williams
Citi analyst P.J. Juvekar views his firm's annual paint survey of nearly 130 U.S. big box, specialty paint and hardware stores as positive for Sherwin-Williams (SHW). The survey showed "healthy" volume growth, particularly for pro painters, and some year-over-year improvement in pricing, Juvekar tells investors in a research note. The analyst prefers shares of Sherwin over PPG (PPG) and Axalta Coating (AXTA).
07/24/17
07/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Blue Apron (APRN) was initiated with a Buy at Goldman Sachs, Stifel, SunTrust, and Canaccord, an Outperform at Oppenheimer and RBC Capital, a Market Perform at William Blair and Raymond James, as well as an Equal Weight at Morgan Stanley and Barclays. 2. Wix.com (WIX) initiated with an Overweight at KeyBanc. 3. Sherwin-Williams (SHW) reinstated with a Neutral at JPMorgan. 4. Aileron Therapeutics (ALRN) was initiated with an Outperform at William Blair, and a Buy at BofA/Merrill, Canaccord, as well as Jefferies. 5. OGE Energy (OGE) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/17
JPMS
07/24/17
INITIATION
Target $365
JPMS
Neutral
Sherwin-Williams reinstated with a Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas reinstated coverage of Sherwin-Williams (SHW) with a Neutral rating and $365 price target. The anlayst prefers PPG (PPG) for its valuation.
07/20/17
JPMS
07/20/17
NO CHANGE
JPMS
Overweight
Home Depot selloff today overdone, says JPMorgan
JPMorgan analyst Christopher Horvers views the selloff today in Home Depot (HD) shares as overdone. Amazon.com's (AMZN) pact to sell Sears' (SHLD) Kenmore appliances and Sherwin-Williams' (SHW) "disappointing" paint performance is dragging the group down, Horvers tells investors in a research note. He points out that Sherwin-Williams and Valspar house paints sell through Lowe's (LOW), and not Home Depot. Further, Amazon doesn't have a white glove infrastructure for appliances, Horvers says. The analyst recommends buying Home Depot amid today's pullback.

TODAY'S FREE FLY STORIES

HAL

Halliburton

$43.33

-0.09 (-0.21%)

, VFC

VF Corp.

$66.38

1.03 (1.58%)

20:25
10/22/17
10/22
20:25
10/22/17
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

VFC

VF Corp.

$66.38

1.03 (1.58%)

STT

State Street

$99.12

1.64 (1.68%)

STX

Seagate

$34.94

0.6 (1.75%)

SALT

Scorpio Bulkers

$8.20

0.45 (5.81%)

LOGI

Logitech

$36.71

0.1 (0.27%)

ITW

Illinois Tool Works

$155.03

1.55 (1.01%)

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

HAS

Hasbro

$98.19

1.52 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

, FB

Facebook

$174.98

0.42 (0.24%)

20:10
10/22/17
10/22
20:10
10/22/17
20:10
Hot Stocks
Catch up on the weekend's top five stories with this list compiled by The Fly: »

1. Tesla has reached an…

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

COH

Coach

$40.35

0.88 (2.23%)

DWDP

DowDuPont

$71.18

0.29 (0.41%)

CZR

Caesars

$12.20

0.15 (1.24%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

SSNLF

Samsung

MS

Morgan Stanley

$50.68

0.89 (1.79%)

UAL

United Continental

$59.90

0.12 (0.20%)

TSLA

Tesla

$345.10

-6.71 (-1.91%)

AET

Aetna

$160.84

3.2 (2.03%)

ANTM

Anthem

$194.69

1.49 (0.77%)

CNC

Centene

$96.50

1.8 (1.90%)

CI

Cigna

$191.42

3.2 (1.70%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

FUL

H.B. Fuller

$57.70

0.63 (1.10%)

20:10
10/22/17
10/22
20:10
10/22/17
20:10
Hot Stocks
H.B. Fuller finalizes acquisition of Royal Adhesives & Sealants »

Boosting H.B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$101.83

-0.37 (-0.36%)

, CMCSA

Comcast

$37.22

0.32 (0.87%)

18:56
10/22/17
10/22
18:56
10/22/17
18:56
Hot Stocks
Box Office Battle: 'Boo 2' wins weekend with $21.7M »

Lionsgate's (LGF.A)…

TWX

Time Warner

$101.83

-0.37 (-0.36%)

CMCSA

Comcast

$37.22

0.32 (0.87%)

CMCSK

Comcast

SNE

Sony

$37.55

0.11 (0.29%)

FOX

21st Century Fox

$26.84

0.14 (0.52%)

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

DIS

Disney

$99.40

0.39 (0.39%)

VIAB

Viacom

$26.70

0.17 (0.64%)

VIA

Viacom

$34.00

-0.05 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

SFNC

Simmons First National

$60.45

0.9 (1.51%)

18:16
10/22/17
10/22
18:16
10/22/17
18:16
Earnings
Simmons First National reports Q3 core EPS 86c, consensus 86c »

Reports Q3 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HLX

Helix Energy

$7.76

-0.13 (-1.65%)

18:09
10/22/17
10/22
18:09
10/22/17
18:09
Earnings
Helix Energy reports Q3 EPS 2c, consensus 2c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GM

General Motors

$45.61

0.26 (0.57%)

18:00
10/22/17
10/22
18:00
10/22/17
18:00
Periodicals
Driverless-car, emerging tech bets help GM shrug off 'dinosaur' image, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GOOG

Alphabet

$988.20

3.75 (0.38%)

, GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

17:42
10/22/17
10/22
17:42
10/22/17
17:42
Periodicals
Alphabet turns on internet balloons in Puerto Rico, AP says »

Alphabet's…

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

AAPL

Apple

$156.25

0.27 (0.17%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

17:30
10/22/17
10/22
17:30
10/22/17
17:30
Periodicals
Facebook, Google spending big money to lobby on Russia, Recode says »

Apple (AAPL), Amazon…

AAPL

Apple

$156.25

0.27 (0.17%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

FB

Facebook

$174.98

0.42 (0.24%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

, UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

17:26
10/22/17
10/22
17:26
10/22/17
17:26
Conference/Events
Union Bankshares to host special shareholder meeting »

Special Shareholder…

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 15

    Nov

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

, XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

17:23
10/22/17
10/22
17:23
10/22/17
17:23
Conference/Events
Xenith Bankshares to host special shareholder meeting »

Special Shareholder…

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ROKA

Roka Bioscience

$1.53

-0.24 (-13.56%)

17:20
10/22/17
10/22
17:20
10/22/17
17:20
Conference/Events
Roka Bioscience to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

17:03
10/22/17
10/22
17:03
10/22/17
17:03
Conference/Events
OceanFirst Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

, SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

16:57
10/22/17
10/22
16:57
10/22/17
16:57
Conference/Events
Sun Bancorp to host special shareholder meeting »

Special Shareholder…

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Oct

  • 15

    Nov

SGU

Star Gas Partners, L.P.

$10.52

-0.16 (-1.50%)

16:49
10/22/17
10/22
16:49
10/22/17
16:49
Conference/Events
Star Gas Partners, L.P. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETRM

EnteroMedics

$2.05

0.07 (3.54%)

16:44
10/22/17
10/22
16:44
10/22/17
16:44
Conference/Events
EnteroMedics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

, SSB

South State

$92.15

-0.2 (-0.22%)

16:39
10/22/17
10/22
16:39
10/22/17
16:39
Conference/Events
South State to host special shareholder meeting »

Special Shareholder…

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

SSB

South State

$92.15

-0.2 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

SSB

South State

$92.15

-0.2 (-0.22%)

, PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

16:36
10/22/17
10/22
16:36
10/22/17
16:36
Conference/Events
Park Sterling Bank to host special shareholder meeting »

Special Shareholder…

SSB

South State

$92.15

-0.2 (-0.22%)

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

, CARO

Carolina Financial

$36.17

0.23 (0.64%)

16:22
10/22/17
10/22
16:22
10/22/17
16:22
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

CARO

Carolina Financial

$36.17

0.23 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CARO

Carolina Financial

$36.17

0.23 (0.64%)

, FSBK

First South Bancorp

$18.66

0.14 (0.76%)

16:19
10/22/17
10/22
16:19
10/22/17
16:19
Conference/Events
First South Bancorp to host special shareholder meeting »

Special Shareholder…

CARO

Carolina Financial

$36.17

0.23 (0.64%)

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

13:41
10/22/17
10/22
13:41
10/22/17
13:41
Periodicals
Fox knew of new harassment settlement before signing O'Reilly, Reuters says »

Forced to resign in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TM

Toyota

$123.71

0.64 (0.52%)

13:37
10/22/17
10/22
13:37
10/22/17
13:37
Periodicals
Toyota to halt operations at Japan plants as typhoon approaches, Reuters says »

Toyota is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

, BAC

Bank of America

$27.17

0.59 (2.22%)

13:34
10/22/17
10/22
13:34
10/22/17
13:34
Hot Stocks
IntercontinentalExchange completes BofA Merrill's Index Platform acquisition »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

BAC

Bank of America

$27.17

0.59 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

VCYT

Veracyte

$9.30

0.11 (1.20%)

13:30
10/22/17
10/22
13:30
10/22/17
13:30
Hot Stocks
Veracyte announces new data, highlights Afirma GSC performance »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$63.88

0.13 (0.20%)

13:19
10/22/17
10/22
13:19
10/22/17
13:19
Hot Stocks
Study shows Merck Zepatier resulted in high sustained virologic response rates »

Merck has announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.